Jumonji Domain-Containing Protein 4 (JMJD4) Antibody

Product Graph
312€ (60 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Jumonji Domain-Containing Protein 4 (JMJD4) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx006052
tested applications
WB

Description

JMJD4 Antibody is a Rabbit Polyclonal Antibody against JMJD4.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Jumonji Domain-Containing Protein 4 (JMJD4)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1/1000 - 1/5000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by affinity chromatography.
Size 1
60 µl
Size 2
120 µl
Size 3
200 µl
Form
Liquid
Tested Applications
WB
Buffer
PBS, pH 7.3, containing 0.02% sodium azide, 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9H9V9
Gene ID
65094
NCBI Accession
NP_075383.2
Background
Antibody anti-JMJD4
Status
RUO
Note
Concentration: 1 mg/ml -

Descripción

Related Products

FNab04441

JMJD4 antibody

Ver Producto
abx006052

Jumonji Domain-Containing Protein 4 (JMJD4) Antibody

JMJD4 Antibody is a Rabbit Polyclonal Antibody against JMJD4.

Ver Producto
abx025007

Jumonji Domain-Containing Protein 4 (JMJD4) Antibody

Covalent modification of histones plays critical role in regulating chromatin structure and transcription. While most covalent histone modifications are reversible, only recently has it been established that methyl groups are subject to enzymatic removal from histones. A family of novel JmjC domain-containing histone demethylation (JHDM) enzymes have been identified that perform this specific function. Histone demethylation by JHDM proteins requires cofactors Fe (II) and alpha-ketoglutarate. Family members include JHDM1 (demethylating histone 3 at lysine 36), and JHDM2A as well as JMJD2CH3K9 (both of which demethylate histone 3 at lysine 9). Contributions of histone demethylase activity to tumor development, decreases in cell proliferation, and hormone-dependent transcriptional activation have been observed.

Ver Producto